|
1
|
Yu X and Li Z: MicroRNA expression and its
implications for diagnosis and therapy of tongue squamous cell
carcinoma. J Cell Mol Med. 20:10–16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Finotello F and Eduati F: Multi-omics
profiling of the tumor microenvironment: paving the way to
precision immuno-oncology. Front Oncol. 8:4302018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim J and Bae JS: Tumor-associated
macrophages and neutrophils in tumor microenvironment. Mediators
Inflamm. 2016:60581472016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang W, Chan CK, Weissman IL, Kim BYS and
Hahn SM: Immune priming of the tumor microenvironment by radiation.
Trends Cancer. 2:638–645. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sahoo SS, Zhang XD, Hondermarck H and
Tanwar PS: The emerging role of the microenvironment in endometrial
cancer. Cancers (Basel). 10(pii): E4082018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Steven A and Seliger B: The role of immune
escape and immune cell infiltration in breast cancer. Breast Care
(Basel). 13:16–21. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Terry S, Savagner P, Ortiz-Cuaran S,
Mahjoubi L, Saintigny P, Thiery JP and Chouaib S: New insights into
the role of EMT in tumor immune escape. Mol Oncol. 11:824–846.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spranger S: Mechanisms of tumor escape in
the context of the T-cell-inflamed and the non-T-cell-inflamed
tumor microenvironment. Int Immunol. 28:383–391. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Barbi J, Pardoll D and Pan F: Treg
functional stability and its responsiveness to the
microenvironment. Immunol Rev. 259:115–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guéry L and Hugues S: Th17 Cell plasticity
and functions in cancer immunity. Biomed Res Int. 2015:3146202015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou X, Su YX, Lao XM, Liang YJ and Liao
GQ: CD19(+)IL-10(+) regulatory B cells affect survival of tongue
squamous cell carcinoma patients and induce resting CD4(+) T cells
to CD4(+)Foxp3(+) regulatory T cells. Oral Oncol. 53:27–35. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sobin LH, Gospodarowicz MK and Wittekind
CH: UICC International Union Against Cancer TNM Classification of
Malignant Tumors. 7th. West Sussex, United Kingdom:
Wiley-Blackwell; 2009
|
|
14
|
Zamarron BF and Chen W: Dual roles of
immune cells and their factors in cancer development and
progression. Int J Biol Sci. 7:651–658. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jadidi-Niaragh F, Ghalamfarsa G, Memarian
A, Asgarian-Omran H, Razavi SM, Sarrafnejad A and Shokri F:
Downregulation of IL-17-producing T cells is associated with
regulatory T cell expansion and disease progression in chronic
lymphocytic leukemia. Tumour Biol. 34:929–940. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Duan MC, Han W, Jin PW, Wei YP, Wei Q,
Zhang LM and Li JC: Disturbed Th17/treg balance in patients with
non-small cell lung cancer. Inflammation. 38:2156–2165. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chaudhary B and Elkord E: Regulatory T
cells in the tumor microenvironment and cancer progression: Role
and therapeutic targeting. Vaccines (Basel). 4(pii): E282016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tanaka A and Sakaguchi S: Regulatory T
cells in cancer immunotherapy. Cell Res. 27:109–118. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Elkord E, Alcantar-Orozco EM, Dovedi SJ,
Tran DQ, Hawkins RE and Gilham DE: T regulatory cells in cancer:
Recent advances and therapeutic potential. Expert Opin Biol Ther.
10:1573–1586. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rasku MA, Clem AL, Telang S, Taft B,
Gettings K, Gragg H, Cramer D, Lear SC, McMasters KM, Miller DM and
Chesney J: Transient T cell depletion causes regression of melanoma
metastases. J Transl Med. 6:122008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ladoire S, Arnould L, Apetoh L, Coudert B,
Martin F, Chauffert B, Fumoleau P and Ghiringhelli F: Pathologic
complete response to neoadjuvant chemotherapy of breast carcinoma
is associated with the disappearance of tumor-infiltrating foxp3+
regulatory T cells. Clin Cancer Res. 14:2413–2420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liang YJ, Lao XM, Liang LZ and Liao GQ:
Genome-wide analysis of cancer cell-derived Foxp3 target genes in
human tongue squamous cell carcinoma cells. Int J Oncol.
46:1935–1943. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li K, Huang SH, Lao XM, Yang L, Liao GQ
and Liang YJ: Interaction of cancer cell-derived Foxp3 and tumor
microenvironment in human tongue squamous cell carcinoma. Exp Cell
Res. 370:643–652. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu S and Qian Y: IL-17/IL-17 receptor
system in autoimmune disease: Mechanisms and therapeutic potential.
Clin Sci (Lond). 122:487–511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen X and Oppenheim JJ: Th17 cells and
Tregs: Unlikely allies. J Leukoc Biol. 95:723–731. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang L, Yi T, Kortylewski M, Pardoll DM,
Zeng D and Yu H: IL-17 can promote tumor growth through an
IL-6-Stat3 signaling pathway. J Exp Med. 206:1457–1464. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
De Simone V, Franzè E, Ronchetti G,
Colantoni A, Fantini MC, Di Fusco D, Sica GS, Sileri P, MacDonald
TT, Pallone F, et al: Th17-type cytokines, IL-6 and TNF-α
synergistically activate STAT3 and NF-kB to promote colorectal
cancer cell growth. Oncogene. 34:3493–3503. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang F, Wang D, Li Y, Sang L, Zhu J, Wang
J, Wei B, Lu C and Sun X: Th1/Th2 balance and Th17/treg-mediated
immunity in relation to murine resistance to dextran
sulfate-induced colitis. J Immunol Res. 2017:70472012017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sun J, Li L, Li L, Ding L, Liu X, Chen X,
Zhang J, Qi X, Du J and Huang Z: Metallothionein-1 suppresses
rheumatoid arthritis pathogenesis by shifting the Th17/Treg
balance. Eur J Immunol. 48:1550–1562. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao L, Yang J, Wang HP and Liu RY:
Imbalance in the Th17/Treg and cytokine environment in peripheral
blood of patients with adenocarcinoma and squamous cell carcinoma.
Med Oncol. 30:4612013. View Article : Google Scholar : PubMed/NCBI
|
